May 30, 2026 02:30PM
May 27, 2026 07:02AM
May 27, 2026 07:00AM
May 13, 2026 04:05PM
Apr 7, 2026 07:01AM
Apr 7, 2026 07:00AM
Mar 25, 2026 04:05PM Precigen Reports Full Year 2025 Financial Results and Business Updates
Jan 20, 2026 08:06AM
Jan 20, 2026 08:05AM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM
Nov 13, 2025 04:05PM
Oct 13, 2025 07:01AM
Oct 13, 2025 07:00AM Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respira
Aug 25, 2025 08:05AM
Aug 19, 2025 06:38AM
Aug 15, 2025 07:00AM
Aug 15, 2025 07:00AM
May 15, 2025 07:22AM
May 14, 2025 04:05PM
Apr 16, 2025 08:05AM Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
Mar 20, 2025 06:41AM
Mar 19, 2025 04:05PM
Feb 25, 2025 09:10AM
Feb 25, 2025 08:05AM
Feb 25, 2025 08:05AM
Jan 13, 2025 07:00AM
Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel
Dec 30, 2024 07:00AM
Nov 14, 2024 04:30PM
Aug 14, 2024 04:05PM
Aug 6, 2024 04:08PM
Aug 6, 2024 04:01PM
Jul 23, 2024 08:01AM
Jul 23, 2024 08:01AM Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
Jun 3, 2024 09:30AM
Jun 3, 2024 09:30AM
May 23, 2024 05:00PM
May 14, 2024 04:05PM
Apr 24, 2024 10:20AM
Mar 28, 2024 04:05PM
Mar 20, 2024 03:16PM JMP Securities Reiterates Market Outperform Rating on Precigen Inc. (PGEN)
Mar 19, 2024 04:05PM
Mar 12, 2024 04:05PM
Jan 16, 2024 08:05AM
Jan 16, 2024 08:05AM
Jan 8, 2024 08:37AM
Jan 8, 2024 08:30AM
Nov 9, 2023 04:55PM Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
Aug 9, 2023 08:00AM

322,212 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All